RecruitingNot ApplicableNCT07367269

Effect of Mandala Coloring on Anxiety, Distress, and Comfort in Breast Cancer Patients Receiving Outpatient Chemotherapy

The Effect of Mandala Coloring on Psychological Distress, Anxiety, and Comfort in Breast Cancer Patients Receiving Outpatient Chemotherapy


Sponsor

Artvin Coruh University

Enrollment

60 participants

Start Date

Jan 27, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Breast cancer patients receiving chemotherapy often experience psychological distress, anxiety, and discomfort during treatment. Non-drug supportive methods may help improve patients' well-being during chemotherapy. This study aims to evaluate whether mandala coloring during outpatient chemotherapy can reduce psychological distress and anxiety and improve comfort in breast cancer patients. Participants will be randomly assigned to either a mandala coloring group or a routine care group. Patients in the intervention group will color mandala patterns for 30 minutes during their chemotherapy session, while the control group will receive routine care only. Psychological distress, anxiety, and comfort levels will be measured before and after the chemotherapy session in both groups. The results of this study may provide evidence for a simple and low-cost supportive intervention to improve the psychological well-being of breast cancer patients during chemotherapy.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Being 18 years of age or older
  • Having a diagnosis of breast cancer and receiving chemotherapy
  • Having no communication problems
  • Having no physical disability that would prevent mandala coloring
  • Being willing to participate in the study

Interventions

BEHAVIORALMandala Coloring

Mandala coloring activity performed for 30 minutes during outpatient chemotherapy using mandala coloring books and colored pencils.


Locations(1)

Artvin State Hospital

Artvin, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07367269


Related Trials